Nonallergic rhinitis

Allergy and Asthma Proceedings

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Shah, Rachna ^a   McGrath, Kris G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DECONGESTIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANETHIDINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HORMONE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN E; METHYLDOPA; NONSTEROID ANTIINFLAMMATORY AGENT; NOSE SPRAY; OXYMETAZOLINE; PHENYLEPHRINE; PHOSPHODIESTERASE V INHIBITOR; PRAZOSIN; PSEUDOEPHEDRINE; PSYCHOTROPIC AGENT; RESERPINE; RISPERIDONE; SILDENAFIL; STEROID; TADALAFIL; THIORIDAZINE; UNINDEXED DRUG;

ALLERGIC RHINITIS; ALLERGY TEST; BACTERIAL INFECTION; CEREBROSPINAL FLUID RHINORRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EOSINOPHILIA; GLAUCOMA; HEAD INJURY; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IDIOPATHIC DISEASE; INFLAMMATORY DISEASE; INSOMNIA; MEDICAL HISTORY; NOSE CONGESTION; NOSE MALFORMATION; NOSE POLYP; NOSE SEPTUM; NOSE SMEAR; PHYSICAL EXAMINATION; PREGNANCY; PROSTATE HYPERTROPHY; PRURITUS; RHINORRHEA; SHORT SURVEY; SKIN TEST; SNEEZING; SYSTEMIC DISEASE; UNSPECIFIED SIDE EFFECT; VASOMOTOR RHINITIS; VIRUS INFECTION;

EID: 84863216317     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3536     Document Type: Short Survey

References (15)

1. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122:S1-S84, 2008. (Pubitemid 352033573)
2. Settipane RA. Rhinitis: A dose of epidemiological reality. Allergy Asthma Proc 24:147-154, 2003. (Pubitemid 37034181)
3. Bernstein DI, and Epstein TG. Nasal polyposis, sinusitis, and nonallergic rhinitis. In Patterson's Allergic Diseases, 7th ed. Grammer LC, and Greenberger PA (Eds). Philadelphia, PA: Lippincott, Williams & Wilkins, 487-497, 2009.
4. Pattanaik D, and Lieberman P. Vasomotor rhinitis. Curr Allergy Asthma Rep 10:84-91, 2010.
5. Orban N, Hesham S, and Durham S. Allergic and Non-allergic rhinitis. In Middleton's Allergy Principles & Practice, 7th ed. Adkinson NF Jr, Bochner BS, Busse WW, et al. (Eds). Philadelphia, PA: Mosby, 973-990, 2008.
6. Kim YH, Oh YS, Kim KJ, and Jang TY. Use of cold dry air provocation with acoustic rhinometry in detecting nonspecific nasal hyperreactivity. Am J Rhinol Allergy 24:260-262, 2010.
7. Dykewicz M, and Hamilos D. Rhinitis and Sinusitis. J Allergy Clin Immunol 125:S103-S115, 2010.
8. Revicki DA, Margolis MK, Thompson CL, et al. Major symptom score utility index for patients with acute rhinosinusitis. Am J Rhinol Allergy 25:99-106, 2011.
9. Settipane RA. Other causes of rhinitis: mixed rhinitis, rhinitis medicamentosa, hormonal rhinitis, rhinitis of the elderly, and gustatory rhinitis. Immunol Allergy Clin North Am 31:457-467, 2011.
10. Carr TF, and Saltoun C. Skin testing in allergy. Allergy Asthma Proc 33:S6-S8, 2012.
11. Smith PK, and Collins J. Olopatadine 0.6% nasal spray protects from vasomotor challenge in patients with severe vasomotor rhinitis. Am J Rhinol Allergy 25:e149-e152, 2011.
12. Lieberman P, Meltzer EO, LaForce CF, et al. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. Allergy Asthma Proc 32:151-158, 2011.
13. Kalpaklioglu AF, and Kavut AB. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis. Am J Rhinol Allergy 24:29-33, 2010.
14. LaForce CF, Carr W, Tilles SA, et al. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. Allergy Asthma Proc 31:132-140, 2010.
15. Kaliner MA. A novel and effective approach to treating rhinitis with nasal antihistamines. Ann Allergy Asthma Immunol 99:383-390, 2007.